A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

However, these medications can work differently for different people, so it’s important to consult a licensed physician ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide ... can be derived from the tablet that we’ve seen from the injectables before.” ...

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day. Subscribe for FREE Patients exploring weight-loss management strategies may elect ...

Sheu and colleagues additionally found that patients in the semaglutide group exhibited similar median HbA1c levels as controls before surgery (5.8% vs. 6%) and 1 year after surgery (5.5% vs.